MedPath

Efficacy of oral steroids to treat the immediate symptoms of food allergy

Not Applicable
Conditions
Food Allergy
Registration Number
JPRN-UMIN000032653
Lead Sponsor
Aichi Children's Health and Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
103
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have a poor physical condition, such as suffering from a cold before undergoing the oral food challenge tests. Patients who had orally taken antihistamines, leukotriene receptor antagonists, beta 2 stimulants, Th 2 cytokine inhibitors, theophylline, or oral sodium cromoglycate within 72 hours before the oral food challenge tests. Patients who received oral or intravenous steroids within 2 weeks before undergoing the oral food challenge tests. Patients that the doctor assessed as being ineligible for other reasons.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The ratio of patients who experienced a worsening the ASCA total score by 10 points or more until the end of the oral food challenge according to intention to treat analysis
Secondary Outcome Measures
NameTimeMethod
The ratio of patients who experienced a worsening the ASCA total score by 10 points or more until the end of the oral food challenge according to per protocol analysis. The ratio of patients who experienced a worsening the ASCA total score by 10 points or more until the end of the oral food challenge, while excluding cases where the ASCA score deteriorated by 10 points or more before the administration of any drugs. The analysis of the efficacy of steroids was stratified according to each organ symptom. The efficacy of the steroids to suppress anaphylaxis and anaphylaxy shock. The analysis of the efficacy of steroids corrected by age, sex, past history of asthma and atopic dermatitis, antigen specific-IgE titer etc.
© Copyright 2025. All Rights Reserved by MedPath